Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil for controlled hypotension during spine surgery
IRCT20241108063640N2Phase 2Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial comparing Dexmedetomidine group with Remifentanil group (2 arms). Primary endpoint: Hypotension control in spine surgery patients. Started Dec 2024; status: completed.
02
Drugs
dexmedetomidineremifentanil
Beyond the preview
Go deeper on IRCT20241108063640N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241108063640N2.